CVSA(CVSA)
CVSA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $2.07B | $2.23B | $2.41B |
| Low | $2.07B | $2.23B | $2.41B |
| High | $2.08B | $2.23B | $2.42B |
| EBITDA Avg | $458M | $494M | $534M |
| Low | $457M | $494M | $534M |
| High | $460M | $494M | $536M |
| EBIT Avg | $281M | $303M | $328M |
| Low | $281M | $303M | $328M |
| High | $283M | $303M | $329M |
| Net Income Avg | $339M | $383M | $423M |
| Low | $334M | $381M | $423M |
| High | $345M | $384M | $425M |
| EPS Avg | $8.89 | $9.96 | $11.04 |
| Low | $8.71 | $9.95 | $11.02 |
| High | $8.99 | $10.01 | $11.10 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $492M | $536M | $517M | $520M |
| Low | $491M | $535M | $516M | $519M |
| High | $492M | $537M | $518M | $520M |
| EBITDA Avg | $109M | $119M | $115M | $115M |
| Low | $109M | $118M | $114M | $115M |
| High | $109M | $119M | $115M | $115M |
| EBIT Avg | $67M | $73M | $70M | $71M |
| Low | $67M | $73M | $70M | $70M |
| High | $67M | $73M | $70M | $71M |
| Net Income Avg | $62M | $90M | $77M | $75M |
| Low | $62M | $90M | $77M | $74M |
| High | $62M | $90M | $77M | $75M |
| EPS Avg | $1.79 | $2.60 | $2.21 | $2.15 |
| Low | $1.79 | $2.59 | $2.21 | $2.14 |
| High | $1.79 | $2.60 | $2.22 | $2.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |